Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-Existing Liver and/or Renal Dysfunction.
暂无分享，去创建一个
H. Kantarjian | J. Cortes | T. Kadia | P. Jain | G. Borthakur | E. Jabbour | N. Daver | S. O'brien | N. Pemmaraju | A. Ferrajoli | Amit Lahoti | S. Pierce | K. Sasaki